Cookies disclaimer

Estoy de acuerdo utilizamos cookies para mejorar la experiencia de navegación del usuario y para estudiar cómo se utiliza nuestro sitio web. si navega por nuestro sitio web, estará aceptando el uso de las cookies en las condiciones establecidas en la presente política de cookies. esta política puede ser actualizada, por lo que le invitamos a revisarla de forma regular

Lipoprotein Deficient Serum, bovine, BT-907 - LPDS - Bovine Serum, lipoprotein deficient - J65182 - Alfa Aesar

J65182 Lipoprotein Deficient Serum, bovine, BT-907

Número CAS
Nombre Alternativo
LPDS
Bovine Serum, lipoprotein deficient

Tamaño Precio ($) Cantidad Disponibilidad
2x25ml 315,00
25ml Pricing available on request. Click Add to Quote Request button and specify size.
Añadir al carrito Añadir al presupuesto al por mayor Ver artículo

Lipoprotein Deficient Serum, bovine, BT-907

Propiedades químicas

Formulario
Liquid

Aplicaciones

Each lot is evaluated in culture with our LDLs to determine the degree of up regulation of LDL receptors. Lipoprotein Deficient Serum, bovine is used for blocking of interfering antibodies. It is evaluated in conjunction with low-density lipoprotein (LDL) to determine the degree of up regulation of low-density lipoprotein receptors.

The absence of lipoproteins allows for the undertaking of binding studies of lipoproteins to cells without the interference of the endogenous lipoproteins.

Notas

Prepared from calf serum. Store frozen (-20° C). Stable for 6-12 months if frozen.

The sequential centrifugation used to produce this human lipoprotein deficient serum removes 99% of the circulating lipoproteins (chylomicrons, VLDL, IDL, LDL HDL) and their associated lipids. What remains in the LPDS is mainly fatty acids bound to proteins such as albumin.

This product is virtually lipoprotein free but not totally lipid free due to the presence of mainly the non-lipoprotein associated fatty acids. There may also be a very small of amount of sterols such as cholesterol bound to some proteins as well.

If there is a need for lipid free serum, then there are multiple protocols in the literature for the production of lipid free serum by the use of organic solvent extraction. Most of those protocols remove 97-99% of the cholesterol, triglycerides, and free fatty acids.

Referencias documentales

Salminen, A.; Åström, P.; Metso, J.; Soliymani, R.; Salo, T.; Jauhiainen, M.; Pussinen, P. J.; Sorsa, T. Matrix metalloproteinase 8 degrades apolipoprotein A-I and reduces its cholesterol efflux capacity. FASEB J. 2015, 29 (4), 1435-1445.

Romagnuolo, R.; Scipione, C. A.; Boffa, M. B.; Marcovina, S. M.; Seidah, N. G.; Koschinsky, M. L. Lipoprotein(a) Catabolism Is Regulated by Proprotein Convertase Subtilisin/Kexin Type 9 through the Low Density Lipoprotein Receptor. J. Biol. Chem. 2015, 290 (18), 11649-11662.

Otras referencias

Código de tarifa arancelaria unificado
3002.19
TSCA
No

Recomendado

  • 10135

    Graphite rod, 6.3mm (0.25in) dia. x 61cm (24in) long, 99% (metals basis)
  • 11278

    Holmium(III) fluoride, anhydrous, REacton®, 99.99% (REO)
  • B24145

    N,N-Dimethyldodecylamine, 90+%
  • B20387

    3-Fluoro-5-(trifluoromethyl)benzyl alcohol, 97%
  • 38449

    Sodium chloride crystal optic disc, 25mm x 2mm, polished both sides

Visto recientemente

Productos químicos

Ciencias de la vida

Metales & materiales

Catalizadores

Análisis y material de laboratorio